Dr. Mark B. Faries, MD

Dr. Faries practices at Cfp Surgical Unit in Los Angeles, California.

Dr. Faries' NPI, 1659428969, was assigned on January 5, 2007. Dr. Faries graduated from Weill Cornell Medicine in 1995. Dr. Faries holds California license A80132.

Dr. Faries' primary practice is Cfp Surgical Unit, at 11818 W Wilshire Blvd, Los Angeles, CA 90025 in Los Angeles County. The practice phone is (310) 828-4008.

Dr. Faries' primary practice is Cfp Surgical Unit in Los Angeles, California. Dr. Faries is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Faries to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Faries practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Faries' primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Faries is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Faries' licenses on file in 3 states: California, Connecticut and Pennsylvania.

Dmand AI lists abdominal adhesion surgery, colon removal and mastectomy among the conditions Dr. Faries treats.

CMS data shows 1,043 Medicare services from Dr. Faries across 21 procedure codes in 2024, for 408 Medicare patients. Medicare paid $133,149 for them.

CMS counts 408 Medicare patients who saw Dr. Faries in 2024. The largest group is 75 to 84, with 178 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Faries' median patient age at 72, with 42% women.

In 2024, Dr. Faries wrote 35 Medicare Part D claims for 23 patients. 97% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $404 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Faries for performance year 2024, reported as part of a group. Dr. Faries accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 124 procedures of melanoma (skin cancer) excision by Dr. Faries, more than 95% of the clinicians it reports for that procedure.

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 109 papers to Dr. Faries, published from 2007 to 2023. 2022 was the busiest year, with 7. The most frequent topics are Melanoma, Skin Neoplasms and Lymphatic Metastasis. Dr. Faries has published most often in Ann Surg Oncol. Dr. Faries' most frequent co-authors are Vernon K. Sondak, MD, Brian J. Czerniecki, MD and Isabelle Bedrosian, MD.

Dmand AI links Dr. Faries to 3 clinical trials. Conditions studied include Melanoma and Nevi and Melanomas.

CMS Open Payments shows 121 general payments to Dr. Faries from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Merck Sharp & Dohme Corporation paid the most, $31,565. It also lists 1 research payment totaling $90 in 2018.

Dmand AI lists 2 awards for Dr. Faries, most recently Top Doctors:LA Area in 2013.

Dr. Faries graduated from Weill Cornell Medicine in 1995. Dr. Faries is a member of ACS.

Dr. Faries is in network with 8 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.